liraglutide a glp 1 Liraglutide, glucagon-like peptide-1 analog, in individuals with obesity in clinical practice Frontiers | Molecular mechanisms of

GLP-1 is released during digestion, binds to receptors that release insulin, and slows down stomach emptying

The study used 36 male Sprague-Dawley rat pup, exposed to 250 mg/kg PPA to induce ASD-lke features, and pre-treated for 27 days with either yogurt, artichoke extract (400 mg/kg), luteolin (50 mg/kg) or Lacticaseibacillus rhamnosus GG (0.2 mL/day)

De La Torre, R., Casado, A., Lpez-Fernndez, E., Carrascosa, D., Ramirez, V

The startups pipeline includes an injectable GLP-1 receptor agonist in Phase I trials, a dual amylin/calcitonin receptor agonist (DACRA) which is being combined with the GLP-1 agonist, as well as a unimolecular GLP-1/GIP/Glucagon in combination with the DACRA